Generation Capital Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VKTX
Generation Capital Management's VKTX Position: Q3 2026 in Review
Generation Capital Management increased its Viking Therapeutics (VKTX) stake by 34% in Q3 2026, buying an estimated $139K and bringing the position to 15,630 shares worth $510K. The position accounts for 0.31% of the portfolio, ranked #62.
Generation Capital Management first reported a position in VKTX in Q2 2025 and has held it in 6 quarters since. 444 funds tracked by Wall St. Rank hold VKTX as of Q3 2026.
- Generation Capital Management held 15,630 shares of Viking Therapeutics worth $510K as of Q3 2026.
- Generation Capital Management bought 4,000 Viking Therapeutics shares in Q3 2026, an estimated $139K.
- Viking Therapeutics made up 0.31% of Generation Capital Management's portfolio in Q3 2026, its #62 holding.
- Generation Capital Management first reported a position in Viking Therapeutics in Q2 2025 and has held it in 6 quarters since.
- 444 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2026.
Based on Generation Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.